Evidence map›Paper›PMID 36113889›Full record

Trial reportBMJ global health2022

The impact of financial incentives on HIV incidence among adolescent girls and young women in Eswatini: Sitakhela Likusasa, a cluster randomised trial.

Marelize Gorgens, Sosthenes Ketende, Andrew F Longosz, Mbuso Mabuza, Muziwethu Nkambule, Tengetile Dlamini, Kelvin Sikwibele, Vimbai Tsododo, Tendai Chipepera, Mxolisi Leroy Ndikandika and 6 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 3 countries.

Marelize GorgensHealth, Nutrition and Population Global Practice, World Bank Group, Washington, DC, USA.
Sosthenes KetendeHealth, Nutrition and Population Global Practice, World Bank Group, Washington, DC, USA.
Andrew F LongoszHealth, Nutrition and Population Global Practice, World Bank Group, Washington, DC, USA.
Mbuso MabuzaNational Emergency Response Council on HIV and AIDS (NERCHA), Mbabane, Eswatini.
Muziwethu NkambuleIndependent (formerly with the National Emergency Response Council on HIV and AIDS), Mbabane, Eswatini.
Tengetile DlaminiNational Emergency Response Council on HIV and AIDS (NERCHA), Mbabane, Eswatini.
Kelvin SikwibeleInstitute for Health Measurement Southern Africa, Mbabane, Eswatini.
Vimbai TsododoInstitute for Health Measurement Southern Africa, Mbabane, Eswatini.
Tendai ChipeperaInstitute for Health Measurement Southern Africa, Mbabane, Eswatini.
Mxolisi Leroy NdikandikaInstitute for Health Measurement Southern Africa, Mbabane, Eswatini.
Wendy HeardHealth, Nutrition and Population Global Practice, World Bank Group, Washington, DC, USA.
Gugu MaphalalaEswatini National Reference Laboratory and National Blood Bank, Ministry of Health, Mbabane, Eswatini.
Lindiwe DlaminiDepartment of Guidance and Counselling, Eswatini Ministry of Education and Training, Mbabane, Eswatini.
David WilsonHealth, Nutrition and Population Global Practice, World Bank Group, Washington, DC, USA.
Damien de WalqueDevelopment Research Group, World Bank Group, Washington, DC, USA ddewalque@worldbank.org.
Khanya MabuzaNational Emergency Response Council on HIV and AIDS (NERCHA), Mbabane, Eswatini.
World Bank Group · USInternational Rescue Committee · ETMinistry of Health · SZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIncentives conditional on school attendance or on remaining free of sexually transmitted infections have produced mixed results in reducing HIV incidence.

methodsHIV-negative adolescent girls and young women aged 15-22%-50% of whom were out of school-were recruited from 293 clusters in Eswatini from urban (30%) and rural areas (70%).Financial incentives conditional on education attendance were randomly allocated at the cluster level. All participants were further individually randomised into eligibility for a raffle incentive conditional on random selection into the raffle, on negative tests for syphilis and

resultsThe study recruited 4389 HIV-negative participants, who were distributed into four subarms: no intervention (n=1068), raffle incentive (n=1162), education incentive (n=1088) and raffle and education incentive (n=1071).At endline, 272 participants from 3772 for whom endline data were collected, tested positive for HIV. HIV incidence among participants in education treatment arm was significantly lower than in the education control arm, 6.34% (119/1878) versus 8.08% (153/1894) (p=0.041); OR: 0.766 (0.598 to 0.981); adjusted OR (aOR): 0.754 (0.585 to 0.972). Compared with the no intervention subarm, HIV incidence in the raffle and education incentive subarm was significantly lower, 5.79% (54/878) versus 8.84% (80/905); OR: 0.634 (0.443 to 0.907); aOR: 0.622 (0.433 to 0.893), while it was not significantly lower in the raffle incentive subarm.

conclusionFinancial incentives conditional on education participation significantly reduced HIV infection among adolescent girls and young women in Eswatini and appear to be a promising tool for prevention in high HIV prevalence settings. TRIAL REGISTRATION NUMBER: Western Institutional Review Board-protocol number 20 141 630.Eswatini National Health Research Review Board-FWA00026661.Pan African Clinical Trials Registry-PACTR201811609257043.

Indexed as

HIV InfectionsMotivationAdolescentEswatiniFemaleHumansIncidencePrevalencecluster randomized trialhealth economicsHIVpublic health

Identifiers

PMID36113889
PMCPMC9486177
OpenAlexW4296163512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.